In terms of being able to access medicines, patients in the Baltic states fare poorly compared to many of their European counterparts. 135 new…

The top 20 companies in the Latvian pharmaceutical market for 2017, sorted by total value and market share, with data on year-on-year growth. American…

As the Lithuanian market matures, profound shifts have been taking place in the arena of human resources and how drug developers go about identifying,…

Vasily and Svetlana Bankovsky, founders of Biosan, talk about the company’s philosophy to develop modern, exciting personal products for sample…

Lukas Savickas, advisor to the prime minister of Lithuania, highlights the changes needed for the Lithuanian life science industry to become more…

Anda Čakša, Latvia’s minister of health since 2016, discusses her current priorities, regulatory reform, areas of strengths and weaknesses in the…

Hubert Niemyjski, country manager of Coloplast Poland and the Baltics, highlights the large differences between the market landscape of the…

Rauno Oja, managing director of AS EGeen, discusses the company’s geographical expansion during his tenure, turning to an international full-service…

Lithuania's key economic indicators between 2015 and 2018: GDP growth, inflation, unemployment rate, and government budget. Lithuania's…

The Top 20 pharma companies in Lithuania by value for 2017. J&J leads the way with a value of around EUR 35 million and market share of 6.3%…

Roland Lepik, cluster head Baltics at Sandoz, discusses the company’s strategy that has allowed it to rank number one in the Estonian market along…

Janis Biezbardis, chairman and owner of Latvian pharmaceutical wholesaler Farmeko, discusses the evolution of the company’s product portfolio, the…